Antonio Arciniegas Rubio

Dr. Antonio Arciniegas Rubio

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
EKEdy Y. Kim
Edy Y. Kim
HNHadas Ner-Gaon
Hadas Ner-Gaon
JVJack Varon
Jack Varon
ACAidan M. Cullen
Aidan M. Cullen
JGJingyu Guo
Jingyu Guo
MBMichael B. Brenner
Michael B. Brenner
As treatment of the early, inflammatory phase of sepsis improves, post-sepsis immunosuppression and secondary infection have increased in importance. How early inflammation drives immunosuppression remains unclear. Although IFN-γ typically helps microbial clearance, we found that increased plasma IFN-γ in early clinical sepsis was associated with the later development of secondary Candida infection. Consistent with this observation, we found that exogenous IFN-γ suppressed macrophage phagocytosis of zymosan in vivo, and antibody blockade of IFN-γ after endotoxemia improved survival of secondary candidemia. Transcriptomic analysis of innate lymphocytes during endotoxemia suggested that NKT cells drove IFN-γ production by NK cells via mTORC1. Activation of invariant NKT (iNKT) cells with glycolipid antigen drove immunosuppression. Deletion of iNKT cells in Cd1d–/– mice or inhibition of mTOR by rapamycin reduced immunosuppression and susceptibility to secondary Candida infection. Thus, although rapamycin is typically an immunosuppressive medication, in the context of sepsis, rapamycin has the opposite effect. These results implicated an NKT cell/mTOR/IFN-γ axis in immunosuppression following endotoxemia or sepsis. In summary, in vivo iNKT cells activated mTORC1 in NK cells to produce IFN-γ, which worsened macrophage phagocytosis, clearance of secondary Candida infection, and mortality.

2 June 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
FBFrancis Boudreault
Francis Boudreault
MPMiguel Pinilla-Vera
Miguel Pinilla-Vera
JEJoshua A. Englert
Joshua A. Englert
AKAlvin T. Kho
Alvin T. Kho
CIColleen Isabelle
Colleen Isabelle
RBRebecca M. Baron
Rebecca M. Baron
Mechanical ventilation is necessary to support patients with acute lung injury, but also exacerbates injury through mechanical stress–activated signaling pathways. We show that stretch applied to cultured human cells, and to mouse lungs in vivo, induces robust expression of metallothionein, a potent antioxidant and cytoprotective molecule critical for cellular zinc homeostasis. Furthermore, genetic deficiency of murine metallothionein genes exacerbated lung injury caused by high tidal volume mechanical ventilation, identifying an adaptive role for these genes in limiting lung injury. Stretch induction of metallothionein required zinc and the zinc-binding transcription factor MTF1. We further show that mouse dietary zinc deficiency potentiates ventilator-induced lung injury, and that plasma zinc levels are significantly reduced in human patients who go on to develop acute respiratory distress syndrome (ARDS) compared with healthy and non-ARDS intensive care unit (ICU) controls, as well as with other ICU patients without ARDS. Taken together, our findings identify a potentially novel adaptive response of the lung to stretch and a critical role for zinc in defining the lung’s tolerance for mechanical ventilation. These results demonstrate that failure of stretch-adaptive responses play an important role in exacerbating mechanical ventilator–induced lung injury, and identify zinc and metallothionein as targets for lung-protective interventions in patients requiring mechanical ventilation.

17 September 2014 in Journal of Aging and Health
Verified
Journal Article
Closed access
Diego Andrés Chavarro-CarvajalDiego Andrés Chavarro-Carvajal
Diego Andrés Chavarro-Carvajal
Carlos Alfonso Reyes-OrtizCarlos Alfonso Reyes-Ortiz
Carlos Alfonso Reyes-Ortiz
RSRafael Samper-Ternent
Rafael Samper-Ternent
ARAntonio Arciniegas Rubio
Antonio Arciniegas Rubio
CCCarlos Cano-Gutierrez
Carlos Cano-Gutierrez
Objective: To determine the nutritional status and factors associated to malnutrition in older adults. Method: Data come from the SABE Bogotá study (Health, Well-Being, and Aging), a cross-sectional survey conducted in Bogotá, Colombia, in 2012 in community-dwelling adults aged 60 years and older. Using the Mini Nutritional Assessment (MNA), we evaluated the nutritional status and factors associated to malnutrition in this population with regression models. Results: From the 1,573 older adults interviewed, 4.58% were malnourished and 34.27% were at risk of malnourishment. Factors associated to malnourishment were older age (odds ratio [OR] =1.02, 95% confidence interval [CI] = [1.00, 1.04]), perceived poor health (OR = 1.46, 95% CI = [1.13, 1.88]), comorbidities (OR = 1.16, 95% CI = [1.04, 1.30]), and low calf circumference (OR = 2.63, 95% CI = [1.86, 3.72]). Having dentures, perception of being well-nourished, and higher functionality decreased the odds for malnourishment (p < .05). Conclusion: The MNA is useful to evaluate factors associated with malnutrition among older adults in Bogotá. Malnutrition is associated with perception of poor health, comorbidities, number of medications, and cognitive impairment.

1 May 2011 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MDMarcus D. Darrabie
Marcus D. Darrabie
ARAntonio Arciniegas Rubio
Antonio Arciniegas Rubio
RMRajashree Mishra
Rajashree Mishra
DBDawn E. Bowles
Dawn E. Bowles
DJDanny O. Jacobs
Danny O. Jacobs
LSLucia Santacruz
Lucia Santacruz
Profound alterations in myocellular creatine and phosphocreatine levels are observed during human heart failure. To maintain its intracellular creatine stores, cardiomyocytes depend upon a cell membrane creatine transporter whose regulation is not clearly understood. Creatine transport capacity in the intact heart is modulated by substrate availability, and it is reduced in the failing myocardium, likely adding to the energy imbalance that characterizes heart failure. AMPK, a key regulator of cellular energy homeostasis, acts by switching off energy-consuming pathways in favor of processes that generate energy. Our objective was to determine the effects of substrate availability and AMPK activation on creatine transport in cardiomyocytes. We studied creatine transport in rat neonatal cardiomyocytes and HL-1 cardiac cells expressing the human creatine transporter cultured in the presence of varying creatine concentrations and the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-d-ribonucleoside (AICAR). Transport was enhanced in cardiomyocytes following incubation in creatine-depleted medium or AICAR. The changes in transport were due to alterations in V max that correlated with changes in total and cell surface creatine transporter protein content. Our results suggest a positive role for AMPK in creatine transport modulation for cardiomyocytes in culture.

21 August 2017 in Physiological Reports
Verified
Journal Article
Open access
PDF file
LSLucia Santacruz
Lucia Santacruz
ARAntonio Arciniegas Rubio
Antonio Arciniegas Rubio
MDMarcus Darrabie
Marcus Darrabie
JMJose G. Mantilla
Jose G. Mantilla
RBRebecca M. Baron
Rebecca M. Baron
DJDanny O. Jacobs
Danny O. Jacobs
Creatine (Cr), phosphocreatine (PCr), and creatine kinases (CK) comprise an energy shuttle linking ATP production in mitochondria with cellular consumption sites. Myocytes cannot synthesize Cr: these cells depend on uptake across the cell membrane by a specialized creatine transporter (CrT) to maintain intracellular Cr levels. Hypoxia interferes with energy metabolism, including the activity of the creatine energy shuttle, and therefore affects intracellular ATP and PCr levels. Here, we report that exposing cultured cardiomyocytes to low oxygen levels rapidly diminishes Cr transport by decreasing Vmax and Km. Pharmacological activation of AMP‐activated kinase (AMPK) abrogated the reduction in Cr transport caused by hypoxia. Cr supplementation increases ATP and PCr content in cardiomyocytes subjected to hypoxia, while also significantly augmenting the cellular adaptive response to hypoxia mediated by HIF‐1 activation. Our results indicate that: (1) hypoxia reduces Cr transport in cardiomyocytes in culture, (2) the cytoprotective effects of Cr supplementation are related to enhanced adaptive physiological responses to hypoxia mediated by HIF‐1, and (3) Cr supplementation increases the cellular ATP and PCr content in RNCMs exposed to hypoxia.

17 June 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
HLHyunwook Lee
Hyunwook Lee
QFQinqin Fei
Qinqin Fei
ASAdam Streicher
Adam Streicher
WZWenjuan Zhang
Wenjuan Zhang
CIColleen Isabelle
Colleen Isabelle
JEJoshua A. Englert
Joshua A. Englert
The acute respiratory distress syndrome (ARDS) is a highly lethal condition that impairs lung function and causes respiratory failure. Mechanical ventilation (MV) maintains gas exchange in patients with ARDS but exposes lung cells to physical forces that exacerbate injury. Our data demonstrate that mTOR complex 1 (mTORC1) is a mechanosensor in lung epithelial cells and that activation of this pathway during MV impairs lung function. We found that mTORC1 is activated in lung epithelial cells following volutrauma and atelectrauma in mice and humanized in vitro models of the lung microenvironment. mTORC1 is also activated in lung tissue of mechanically ventilated patients with ARDS. Deletion of Tsc2 , a negative regulator of mTORC1, in epithelial cells impairs lung compliance during MV. Conversely, treatment with rapamycin at the time MV is initiated improves lung compliance without altering lung inflammation or barrier permeability. mTORC1 inhibition mitigates physiologic lung injury by preventing surfactant dysfunction during MV. Our data demonstrate that, in contrast to canonical mTORC1 activation under favorable growth conditions, activation of mTORC1 during MV exacerbates lung injury and inhibition of this pathway may be a novel therapeutic target to mitigate ventilator-induced lung injury during ARDS.